DULCOLAX SUPPOSITORY

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

BISACODYL

から入手可能:

SANOFI CONSUMER HEALTH INC

ATCコード:

A06AB02

INN（国際名）:

BISACODYL

投薬量:

10MG

医薬品形態:

SUPPOSITORY

構図:

BISACODYL 10MG

投与経路:

RECTAL

パッケージ内のユニット:

3/6/100

処方タイプ:

OTC

治療領域:

CATHARTICS AND LAXATIVES

製品概要:

Active ingredient group (AIG) number: 0101506002; AHFS:

認証ステータス:

APPROVED

承認日:

2019-12-09

製品の特徴

_ _
_Dulcolax Prescribing Information _
_Page 1 of 12 _
PRESCRIBING INFORMATION
DULCOLAX
®
Bisacodyl
Tablets 5 mg
Suppositories 10 mg
Manufacturer’s Standard
Stimulant Laxative
sanofi-aventis Canada Inc.
2905 Louis-R.-Renaud Place
Laval, Quebec H7V 0A3
Date of Revision:
November 7, 2017
Submission Control No:210082
CCDS: 0074-07
_ _
_Dulcolax Prescribing Information _
_Page 2 of 12 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
.....................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
...............................................................................4
ADVERSE REACTIONS
....................................................................................................5
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................7
STORAGE AND STABILITY
............................................................................................7
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................8
PART III: CONSUMER
INFORMATION................................................................................9
PART III: CONSUMER
INFORMATION..............................................................................11
_ _
_Dulcolax Prescribing Information _
_Page 3 of 12 _
DULCOLAX
®
Bisacodyl
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF
ADMINISTRATION
DOSAGE FORM /
STRENGTH
CLINICALLY RELEVANT NONMEDICINAL INGREDIENTS
Oral
tablet 5 mg
acacia, white wax, carnauba wax, corn starch
(dried/soluble), methacry